A Study of Enfortumab Vedotin in Japanese Subjects With Locally Advanced or Metastatic Urothelial Carcinoma
Clinical trial NCT03070990 · COMPLETED
Trial details
- NCT number
- NCT03070990
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-24
- Primary completion
- 2019-02-25
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.